GSK3145095

CAS No: 1622849-43-7

1622849-43-7
2160546-07-4 LACS-13909
1923844-48-7 Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]-
1622849-43-7 GSK3145095
2291164-02-6 GS-4361
2409963-83-1 2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2Z)-
1192171-69-9 Vonafexor
2162982-11-6 BAY-218
1715025-32-3 ERK-IN-1
2102501-84-6 Ketohexokinase inhibitor 1
2173556-69-7 Carbamic acid, N-[5-[2-(acetylamino)-6-benzothiazolyl]-2-methyl-3-pyridinyl]-, cyclohexyl ester
2180127-82-4 BMS-615
1809885-32-2 EC-5026
1403859-14-2 CC-90001
2173134-00-2 vanin-1 inhibitor
2569009-58-9 Benzenesulfonamide, 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]-
1293281-49-8 Seltorexant
1933528-96-1 MDR652
2226735-55-1 GSK547
2101626-26-8 GSK2894631A
2266569-73-5 UMB298
1622849-43-7 ,1622849-43-7
2025-12-28 Discover GSK3145095 (CAS No: 1622849-43-7) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.